Datasets for next-generation sequencing of DNA and RNA from urine and plasma of patients with prostate cancer

Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the whole transcriptome profiling by RNA-seq of urine...

Full description

Saved in:

Bibliographic Details
Published in:	Data in brief Vol. 10; no. C; pp. 369 - 372
Main Authors:	Nikitina, A.S., Sharova, E.I., Danilenko, S.A., Selezneva, O.V., Butusova, T.B., Vasiliev, A.O., Govorov, A.V., Prilepskaya, E.A., Pushkar, D.Y., Kostryukova, E.S.
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Inc 01-02-2017 Elsevier
Subjects:	Benign prostatic hyperplasia Data Prostate cancer RNA-seq Targeted DNA sequencing Transcriptome Benign prostatic hyperplasia Targeted DNA sequencing RNA-seq Prostate cancer Transcriptome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the whole transcriptome profiling by RNA-seq of urine and plasma obtained from patients with PCa and benign prostatic hyperplasia (BPH). The second one represents targeted sequencing of DNA from urine and plasma of patients with PCa and BPH. Both datasets are available at NCBI Sequence Read Archive under Accession No. SRP093707 and No. SRP093842 respectively.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2352-3409 2352-3409
DOI:	10.1016/j.dib.2016.12.016